BioCentury

7:00 AM GMT, Oct 1, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Finance

4Q milestones

4Q milestones

Company Product Standard indication Event Milestone
Accentia (ABPI) SinuNase Sinusitis Ph III data YE07
Acusphere (ACUS)/Nycomed Imagify (AI-700) Cardiovascular Submit NDA 4Q07
Adams Respiratory (ARXT) Extended-release guaifenesin combination Cough PDUFA date Oct. 27
Adv Life Sci (ADLS) Cethromycin Pneumonia Ph III data; submit NDA November; YE07
Aeterna Zentaris (TSX:AEZ; AEZS)/Ardana (LSE:ARA) ARD-07 (Formerly EP-1572) Growth hormone deficiency Ph III data; submit NDA November; YE07
AMAG Pharma (AMAG) Ferumoxytol Anemia Submit NDA 4Q07
Amgen (AMGN) AMG 531 Idiopathic thrombocytopenic purpura (ITP) US and EU regulatory submissions YE07
Amylin (AMLN)/Eli Lilly (LLY)/Alkermes (ALKS) Exenatide

Read the full 985 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.